Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018974
Fusion event
HBV-IGF2R integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Host Sequence
Chromosome
chr6
Cytoband
q25.3
Reference genome
End
160521840/160100808 (Hg38)
Location type
Intron45
Target gene
miRNAs that regulate target gene
hsa-mir-16-5p ; hsa-mir-657 ; hsa-mir-155-5p ; hsa-mir-9-5p ; hsa-mir-26b-5p ; hsa-mir-1271-5p ; hsa-mir-423-3p ; hsa-mir-128-3p ; hsa-mir-211-5p ; hsa-mir-545-5p ; hsa-mir-412-3p ; hsa-mir-377-3p ; hsa-mir-218-5p ; hsa-mir-96-3p ; hsa-mir-2681-3p ; hsa-mir-548m ; hsa-mir-8485 ; hsa-mir-7977 ; hsa-mir-4284 ; hsa-mir-24-3p ; hsa-mir-564 ; hsa-mir-6860 ; hsa-mir-612 ; hsa-mir-5189-5p ; hsa-mir-3187-5p ; hsa-mir-1285-3p ; hsa-mir-383-3p ; hsa-mir-342-3p ; hsa-mir-6777-3p ; hsa-mir-6089 ; hsa-mir-561-5p ; hsa-mir-6715b-3p ; hsa-mir-4742-3p ; hsa-mir-6715a-3p ; hsa-mir-1178-5p ; hsa-mir-649 ; hsa-mir-106a-3p ; hsa-mir-1296-5p ; hsa-mir-6877-5p ; hsa-mir-4480 ; hsa-mir-5008-5p ; hsa-mir-3146 ; hsa-mir-454-3p ; hsa-mir-4295 ; hsa-mir-3666 ; hsa-mir-301b-3p ; hsa-mir-301a-3p ; hsa-mir-130b-3p ; hsa-mir-130a-3p ; hsa-mir-4512 ; hsa-mir-6895-5p ; hsa-mir-519c-3p ; hsa-mir-519b-3p ; hsa-mir-519a-3p ; hsa-mir-1247-3p ; hsa-mir-1827 ; hsa-mir-1910-3p ; hsa-mir-3612 ; hsa-mir-4537 ; hsa-mir-455-3p ; hsa-mir-4756-3p ; hsa-mir-5186 ; hsa-mir-5694 ; hsa-mir-6499-3p ; hsa-mir-650 ; hsa-mir-6511a-5p ; hsa-mir-6516-5p ; hsa-mir-4252 ; hsa-mir-4719 ; hsa-mir-551b-5p
Nearest miRNA
hsa-mir-10398/Upstream/1335968; hsa-mir-1913/Downstream/6408546;
Nearest CpG islands
None/Target, chr6-CpG: 120/Upstream/9288, chr6-CpG: 55/Downstream/32821
Nearest cancer related gene
IGF2R(TSG, No orient, 0)
Upstream sequence
gagatagatgcatactctgattgcctcctttggaaaggtttatcagaaactcaaaagtaagacctggcagccccctccctgctttgtccccgcctttctg
Downstream sequence
gagacagagacttgctcttttgcccaggctggagtgcagtggtgcgatcttggctcactgcaacctctgcttcccagattcaagtgattctcatgcctca
Target sequence
ccctttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttg
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.